In the tropics, carnivorous plants trap unsuspecting prey in a cavity filled with liquid known as a "pitcher."
The moment insects like flies, ants and beetles fall into a pitcher, the plant's enzymes are activated and begin dissolving their new meal, obtaining nutrients such as carbon and nitrogen which are difficult to extract from certain soils. Carnivorous plants also possess a highly developed set of compounds and secondary metabolites to aid in their survival.
These compounds could serve as a new class of anti-fungal drugs for use in human medicine, says Prof. Aviah Zilberstein of Tel Aviv University's Department of Plant Sciences. In a study conducted together with Dr. Haviva Eilenberg from her lab, Prof. Esther Segal from the Sackler Faculty of Medicine and Prof. Shmuel Carmeli from the School of Chemistry, the unusual components from the plants’ pitchers were found effective as anti-fungal drugs against human fungal infections widespread in hospitals. The primary results are encouraging.
"To avoid sharing precious food resources with other micro-organisms such as fungi, the carnivorous plant has developed a host of agents that act as natural anti-fungal agents," says Prof. Zilberstein. "In the natural habitat of the tropics, competition for food is fierce, and the hot, moist environment is perfect for fungi, which would also love to eat the plant's insect meal."
Highly resistant and 100% organic
After initial tests of the plant proteins and enzymes that dissolve the chitin of fungi, Prof. Zilberstein assumes that, in the right clinical conditions, the pitcher secondary metabolites can be developed to effective anti-fungal drugs, that may avoid the evolution of new resistant infective strains.
The collaborating team has just published a paper exploring that potential in the Journal of Experimental Biology, based on the biology of the carnivorous plant Nepenthes khasiana. This plant species is originally found in India but is also being reared in Tel Aviv University greenhouses.
Currently there is a need for additional broadly effective anti-fungal drugs. Even mildly severe forms of athlete's foot or other skin fungal infections lack effective treatments. The problem becomes more dire at hospitals, where thousands of Americans die each year from secondary fungal infections they acquire during their stay as patients.
Forging a “wild” pathway in drug discovery
The collaborating team has determined plant secondary metabolites that function as anti-fungal agents. "The pitcher of the carnivorous plant produces these compounds in a gland," says Prof. Zilberstein. Until now, no one has published or discussed the anti-fungal metabolites found in the trap liquid of this plant, she says.
"We're hoping that these metabolites are working together to keep fungus at bay. Our aim now is to get funding for pre-clinical tests of these compounds in an animal model, so we can investigate their effectiveness against the two very acute fungal pathogens found in hospitals worldwide," she says.
The idea that liquid from a plant pitcher could stave off infection has been documented in the folk literature of India, where people drink carnivorous plant pitcher juice as a general elixir. "There is a lot of room for developing compounds from nature into new drugs," says Prof. Zilberstein. "The one we are working on is not toxic to humans. Now we hope to show how this very natural product can be further developed as a means to overcome some basic problems in hospitals all over the world."
George Hunka | EurekAlert!
Warming ponds could accelerate climate change
21.02.2017 | University of Exeter
An alternative to opioids? Compound from marine snail is potent pain reliever
21.02.2017 | University of Utah
In the field of nanoscience, an international team of physicists with participants from Konstanz has achieved a breakthrough in understanding heat transport
Cells need to repair damaged DNA in our genes to prevent the development of cancer and other diseases. Our cells therefore activate and send “repair-proteins”...
The Fraunhofer IWS Dresden and Technische Universität Dresden inaugurated their jointly operated Center for Additive Manufacturing Dresden (AMCD) with a festive ceremony on February 7, 2017. Scientists from various disciplines perform research on materials, additive manufacturing processes and innovative technologies, which build up components in a layer by layer process. This technology opens up new horizons for component design and combinations of functions. For example during fabrication, electrical conductors and sensors are already able to be additively manufactured into components. They provide information about stress conditions of a product during operation.
The 3D-printing technology, or additive manufacturing as it is often called, has long made the step out of scientific research laboratories into industrial...
Nature does amazing things with limited design materials. Grass, for example, can support its own weight, resist strong wind loads, and recover after being...
Nanometer-scale magnetic perforated grids could create new possibilities for computing. Together with international colleagues, scientists from the Helmholtz Zentrum Dresden-Rossendorf (HZDR) have shown how a cobalt grid can be reliably programmed at room temperature. In addition they discovered that for every hole ("antidot") three magnetic states can be configured. The results have been published in the journal "Scientific Reports".
Physicist Dr. Rantej Bali from the HZDR, together with scientists from Singapore and Australia, designed a special grid structure in a thin layer of cobalt in...
13.02.2017 | Event News
10.02.2017 | Event News
09.02.2017 | Event News
21.02.2017 | Earth Sciences
21.02.2017 | Medical Engineering
21.02.2017 | Trade Fair News